BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會

講師

訊聯生技集團 - Advanced Cell Therapies in the COVID-19 Pandemic/post-Pandemic Era

Advanced Cell Therapies in the COVID-19 Pandemic/post-Pandemic Era

Date:July 21 (Wed) 2021
Time:15:40-17:40

自2019年底開始,由新型冠狀病毒感染所引發(COVID-19)疫情蔓延全球,各國積極研發應對政策。近年全球細胞療法發展加速,透過幹細胞的修復與免疫調節功能,治療COVID-19的臨床試驗也急速增加。

本次線上座談會集結各國醫師與學者,分別來自印尼、日本、馬來西亞、新加坡、泰國、台灣等國,分享各國細胞治療近況,說明在疫情與後疫情時代中,細胞治療如何成為重症治療新希望。

Agenda

Duration
Topic / Speaker
15:40 - 15:49

Opening Remarks
Chairperson:
Advanced Cell Therapies in the COVID-19 Pandemic/post-Pandemic Era.

Dr. Tokiko Nagamura-Inoue / MD, PhD, Hospital professor.
Research hospital, Inst. of Medical Science, Univ. of Tokyo, Japan.
 

Section1  Moderator:

Dr. Chang-Yao Tsao / MD, PhD, Professor.
Internal of Medicine, Director, Immune Cell Therapy Unit,Chung Shan Medical University, Taichung, Taiwan.
15:49 - 16:03

Human Umbilical Cord-Derived Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome.

Dr.Hon-Kan Yip/Professor Level Attending Physician.
Kaohsiung Chang Gung Memorial Hospital, Taiwan.
16:03 - 16:16

Mesenchymal stem cell therapy for severe COVID-19: Sharing experience from Thailand

Dr. Sithakom Phusanti
Deputy Director and Chief of Information Officer (CIO)/ Physician (Hematologist, Internist)
Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Thailand.
16:16 - 16:31

Applications of mesenchymal stem cells in immune disorders and lung injury, including severe COVID-19 infection.

Dr. Kang-Hsi Wu/ MD, Vice superintendent.
Chung Shan Medical University Hospital, Taichung, Taiwan.
16:31 - 16:45

Umbilical cord mesenchymal stromal cell as critical COVID-19 adjuvant therapy.

Professor Ismail H Dilogo/ MD, PhD.
Stem Cell Medical Technology Integrated Service Unit, Cipto
Mangunkusumo Central Hospital, Faculty of Medicine University Indonesia, Jakarta, Indonesia.
16:45 - 16:54

Section1 Panel Discussion

Moderator: Dr. Chang-Yao Tsao
Panelists: Dr.Hon-Kan Yip/Dr. Sithakom Phusanti/Dr. Kang-Hsi Wu/Professor Ismail H Dilogo
16:54 - 16:54

Section2 Moderator:

Dr. Tokiko Nagamura-Inoue / MD, PhD, Hospital professor.
Research hospital, Inst. of Medical Science, Univ. of Tokyo, Japan.
16:54 - 17:05

The promise of cell therapy for pediatric acute/chronic lung disease: clinical case sharing.

Dr. Pei-Chen Tsao/ Director of neonatal intensive care unit.
Taipei Veterans General Hospital, Taiwan.
17:05 - 17:13

Stem Cells Technology 4.0 in Anti-Ageing and Anti-COVID

Professor Phan Toan-Thang / Founding Director and Chief Scientific Officer
Cell Research Corporation, Singapore.
17:13 - 17:29

The anti-inflammatory and Immunomodulatory actions of human umbilical cord derived mesenchymal stem cells: Clinical Perspectives.

Dr. Chin Sze-Piaw / Clinical and Research Advisor
CYTOPEUTICS & Honorary Fellow of the Centre for Stem Cell Research (CSCR), Faculty of Medicine and Health Sciences, University Tunku Abdul Rahman (UTAR), Malaysia.
17:29 - 17:40

Section2 Panel Discussion/ Final Conclusions

Moderator: Dr. Tokiko Nagamura-Inoue
Panelists: Dr. Pei-Chen Tsao/Dr. Ivor Lim/Dr. Chin Sze-Piaw
Organizer: Chris Tsai-Chairman of BIONET Corp. /Dr. Wen-Chien Lee- President of Asian Federation of Biotechnology.

Introduction

Company Info

Company Name: BIONET Corp.
Address: No.28, Ln.36, Xinhu 1st Rd., Neihu Dist., Taipei City 11494, Taiwan
Website: www.bionetcorp.com

Contact

Name: Yvonne Lin
Title: Senior Public Relations Executive
Email: Yvonnelin@bionetcorp.com
Phone: (Work)(02)2795-1777#1567
Mobile:0952-301-686

Company Type

Biotechnology

Company Introduction

訊聯生技集團創立於1999年,致力精準醫學及再生醫學,積極發展細胞治療應用、基因檢測、科學資訊三大核心項目,集團所提供的各項細胞、基因、檢測、醫美保養品等產品技術,已服務全台超過40%新生兒、90%生殖醫學中心,亦拓展至海外17國, 總體客戶數達140萬以上,滿足客戶不同人生階段的健康需求。